Insights into the pathophysiology of unstable coronary artery disease

American Journal of Cardiology

Volumn 80, Issue 5 A, 1997, Pages

  Kristensen, Steen Dalby ^a   Ravn, Hanne Berg ^a   Falk, Erling ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; GLYCOPROTEIN IIIA;

ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; HEART INFARCTION; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RUPTURE;

EID: 0030815555     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00482-7     Document Type: Conference Paper

References (34)

1. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J. 50:1983;127-134.
2. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 310:1984;1137-1140.
3. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 71:1985;699-708.
4. Davies MJ, Thomas AC, Knapman PA, Hangartner JR. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation. 73:1986;418-427.
5. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 303:1980;897-902.
6. Sherman CT, Litvack F, Grundfest W, Lee M, Hickey A, Chaux A, Kass R, Blanche C, Matloff J, Morgenstern L. Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med. 315:1986;913-919.
7. De Feyter PJ, Ozaki Y, Baptista J, Escaned J, Dimario C, Dejaegere PPT, Serruys PW, Roelandt JRTC. Ischemia-related lesion characteristics in patients with stable or unstable angina - A study with intracoronary angioscopy and ultrasound. Circulation. 92:1995;1408-1413.
8. Tabata H, Mizuno K, Arakawa K, Satomura K, Shibuya T, Kurita A, Nakamura H. Angioscopic identification of coronary thrombus in patients with postinfarction angina. J Am Coll Cardiol. 25:1995;1282-1285.
9. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:1993;801-809.
10. Fuster V, Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 90:1994;2126-2146.
11. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 92:1995;657-671.
12. Geng Y-J, Libby P. Evidence for apoptosis in advanced human atheroma - Colocalization with interleukin-1-β-converting enzyme. Am J Pathol. 147:1995;251-266.
13. Davies MJ, Bland JM, Hangartner JR, Angelini A, Thomas AC. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. Eur Heart J. 10:1989;203-208.
14. Bruschke AV, Kramer JR Jr, Bal ET, Haque IU, Detrano RC, Goormastic M. The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. Am Heart J. 117:1989;296-305.
15. Mann JM, Davies MJ. Vulnerable plaque - relation of characteristics to degree of stenosis in human coronary arteries. Circulation. 94:1996;928-931.
16. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 69:1993;377-381.
17. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation. 90:1994;775-778.
18. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 91:1995;2844-2850.
19. Muller JE, Abela GS, Nesto RW, Tofler GH. Triggers, acute risk factors and vulnerable plaques: The lexicon of a new frontier. J Am Coll Cardiol. 23:1994;809-813.
20. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol. 23:1994;1562-1569.
21. Toschi V, Gallo R, Lettino M, Fallon JF, Gertz SD, Fernandezortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 95:1997;594-599.
22. Moreno PR, Bernardi VH, López-Cuéllar J, Murcia AM, Palacios IF, Gold HK, Mehran R, Sharma SK, Nemerson Y, Fuster V, Fallon JT. Macrophages, smooth muscle cells, and tissue factor in unstable angina - implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation. 94:1996;3090-3097.
23. Kristensen SD. The platelet-vessel wall interaction in experimental atherosclerosis and ischaemic heart disease with special reference to thrombopoiesis. Dan Med Bull. 39:1992;110-127.
24. Milner PC, Martin JF. Shortened bleeding time in acute myocardial infarction and its relation to platelet mass. BMJ. 290:1985;1767-1770.
25. Kristensen SD, Bath PM, Martin JF. Differences in bleeding time, aspirin sensitivity and adrenaline between acute myocardial infarction and unstable angina. Cardiovasc Res. 24:1990;19-23.
26. Trowbridge EA, Martin JF. The platelet volume distribution: A signature of the prethrombotic state in coronary heart disease? Thromb Haemost. 58:1987;714-718.
27. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA. Platelet activation in unstable coronary disease. N Engl J Med. 315:1986;983-989.
28. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet. 338:1991;1409-1411.
29. Trip MD, Cats VM, van Capelle FJL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 322:1990;1549-1554.
30. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med. 334:1996;1090-1094.
31. Newman PJ. Platelet alloantigens - cardiovascular as well as immunological risk factors? Lancet. 349:1997;370-371.
32. 2) polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke and venous thrombosis. Lancet. 349:1997;385-388.
33. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 332:1995;635-641.
34. Maseri A, Biasucci LM, Liuzzo G. Inflammation in ischaemic heart disease - C reactive protein concentrations may provide useful information on risk. BMJ. 312:1996;1049-1050.